Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
AstraZeneca
Harvard Business School
Medtronic
Moodys

Last Updated: January 19, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Tradipitant


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Tradipitant?

Tradipitant is an investigational drug.

There have been 10 clinical trials for Tradipitant. The most recent clinical trial was a Phase 3 trial, which was initiated on October 21st 2019.

The most common disease conditions in clinical trials are Dermatitis, Atopic, Dermatitis, and Eczema. The leading clinical trial sponsors are Vanda Pharmaceuticals, Cross Research S.A., and Mayo Clinic.

There are sixteen US patents protecting this investigational drug and one hundred and seventy-seven international patents.

Recent Clinical Trials for Tradipitant
TitleSponsorPhase
Effects of Tradipitant on Satiation, Gastric Volume, Gastric Accommodation, and Gastric Emptying in Healthy VolunteersMayo ClinicPhase 1
Effects of Tradipitant on Satiation, Gastric Volume, Gastric Accommodation, and Gastric Emptying in Healthy VolunteersVanda PharmaceuticalsPhase 1
ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 InfectionVanda PharmaceuticalsPhase 3

See all Tradipitant clinical trials

Clinical Trial Summary for Tradipitant

Top disease conditions for Tradipitant
Top clinical trial sponsors for Tradipitant

See all Tradipitant clinical trials

US Patents for Tradipitant

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Tradipitant ⤷  Try it Free Intermediate and process useful in the preparation of {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1H-[1,2,3]triazol-4- -yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone ELI LILLY AND COMPANY (Indianapolis, IN) ⤷  Try it Free
Tradipitant ⤷  Try it Free Controlled release dosage form TRIASTEK, INC. (Nanjing, CN) ⤷  Try it Free
Tradipitant ⤷  Try it Free Oral drug dosage forms having desired drug release profiles and uses thereof Triastek, Inc. (Nanjing, CN) ⤷  Try it Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
AstraZeneca
Harvard Business School
Medtronic
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.